As a GLP-1 receptor agonist, semaglutide suppresses appetite, delays stomach emptying, and stimulates insulin secretion.[1] While semaglutide was originally developed for patients with T2D as a glucose-lowering medication, clinical trials later demonstrated significant weight loss in patients taking semaglutide.[6] Additional studies also support semaglutides effectiveness in promoting weight loss for non-diabetics.[1,7,8] Wegovy is the only semaglutide medication approved by the U.S
Perkovic V., Tuttle K.R., Rossing P., et al
With a list of associated health problems that could rival a horror movie marathon, it's time to find the superhero to save the day
Proven Results and Expert Team : Backed by clinical trials and evidence-based practices, semaglutide has been shown to deliver real results, and the expert team at New Jersey Trim Clinic guides patients every step of the way towards a happier, healthier life
The resulting historic supply shortages carved out a temporary secondary market for compounded tirzepatide
